Phibro Animal Health Q3 2024 Adj EPS $0.31 Beats $0.29 Estimate, Sales $263.200M Beat $254.825M Estimate
Phibro Animal Health Q3 2024 Adj EPS $0.31 Beats $0.29 Estimate, Sales $263.200M Beat $254.825M Estimate
Phibro Animal Health 2024年第三季度调整后的每股收益为0.31美元，超过预期的0.29美元，销售额为2.632亿美元，超过2.54825亿美元的预期
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.29 by 6.9 percent. This is a 6.9 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $263.200 million which beat the analyst consensus estimate of $254.825 million by 3.29 percent. This is a 7.12 percent increase over sales of $245.700 million the same period last year.
Phibro Animal Health（纳斯达克股票代码：PAHC）公布的季度收益为每股0.31美元，比分析师普遍预期的0.29美元高出6.9％。这比去年同期每股收益0.29美元增长了6.9％。该公司公布的季度销售额为2.632亿美元，比分析师普遍预期的2.54825亿美元高出3.29％。这比去年同期的2.457亿美元销售额增长了7.12％。